Legal Representation
Attorney
Douglas R. Wolf
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 9, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 18, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 18, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 30, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 28, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 6, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 6, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 6, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Sep 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 12, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 7, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 12, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 27, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 12, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 7, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 12, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 9, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 9, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 9, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 24, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 24, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 24, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 15, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 040
Custom manufacture of reformulated pharmaceuticals in the field of cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines; custom reformulation of pharmaceuticals for easier patient delivery
First Use Anywhere:
20220400
First Use in Commerce:
20220400
Class 044
Providing information to patients in the fields of administering medication and how medicines are designed to bring patients new formulations and dosage innovations to help them benefit from existing medicines
First Use Anywhere:
20220400
First Use in Commerce:
20220400
Classification
International Classes
040
044